Since it has been demonstrated that myocardial GRK2 levels and activity mirror those measured in peripheral lymphocytes in HF patients (Iaccarino et al., 2005), it could be possible to monitor the efficacy of different therapies using circulating white blood cells (Rengo et al., 2013b). Here, GRK2 is linked to hydrops fetalis.